ctrl K

Price Alert

Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

6.64

-0.27 (-3.91%)

At close: Aug 20, 2025, 9:48 AM

Sagimet Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	75.84M	75.14M	158K	56.73M
Short-Term Investments	75.41M	19.76M	32.19M	n/a
Long-Term Investments	7.41M	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	27K	27K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	463K	397K	95K	1.51M
Total Current Assets	152.77M	96.65M	32.79M	58.66M
Property-Plant & Equipment	77K	73K	212K	342K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.49M	73K	239K	369K
Total Assets	160.26M	96.72M	33.03M	59.03M
Account Payables	1.43M	186K	1.13M	761K
Deferred Revenue	n/a	n/a	3.96M	n/a
Short-Term Debt	78K	65K	133K	124K
Other Current Liabilities	-73K	491K	-4.04M	61K
Total Current Liabilities	4.45M	5.65M	5.28M	2.44M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	4K	214.63M
Total Long-Term Liabilities	n/a	n/a	214.7M	214.85M
Total Liabilities	4.45M	5.65M	219.98M	217.29M
Total Debt	78K	65K	211K	348K
Common Stock	3K	2K	1K	1K
Retained Earnings	-295.31M	-249.74M	-221.87M	-191.37M
Comprehensive Income	230K	30K	-84K	-214.63M
Shareholders Equity	155.81M	91.06M	27.67M	56.37M
Total Investments	82.82M	19.76M	32.19M	n/a